Global injury associated with blepharoplasty is rare but serious, study suggests

News
Article

Study investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with one case of traumatic cataract.

Patient's eyelid being prepped for blepharoplasty procedure Image credit: AdobeStock/RabizoAnatolii

Image credit: AdobeStock/RabizoAnatolii

Blepharoplasty is a frequently performed ophthalmic surgery. As with any procedure, even the commonly performed ones, there are associated adverse events. For blepharoplasty, these include infection, bleeding, and excessive or incomplete fat removal among others.

First author Benjamin Meyer, MD, and colleagues reported that global injuries, although rare, also can occur and urged that they be addressed promptly.1 He is from the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami.

In this study, the authors reported a case series and literature review with a total of 16 cases of global injury following blepharoplasty.

The investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with 1 case of traumatic cataract.

“The median time from surgery to symptom onset was 1 day, with a concerning median delay of 7 days to presentation to an ophthalmologist. Visual outcomes were generally poor, with nearly all patients experiencing permanent visual morbidity,” they reported.

In addition, endophthalmitis developed in 3 cases that were reported in the systemic review that occurred following perforating scleral injuries.

A comparison of penetrating and perforating injuries showed no differences in the visual outcomes.

Meyer and colleagues called for increased vigilance for globe injuries that require prompt ophthalmologic evaluation following blepharoplasty. They especially emphasized the delayed presentation and the degree of the visual morbidity

“The study advocates for improved practitioner training in recognizing and managing these complications and underscores the importance of patient education regarding the potential risks and the necessity of timely postoperative care,” they concluded.

Reference:
  1. Meyer BI, Shoji MK, Zamani KA, et al. Beyond the surface: a systematic review of perforating and penetrating globe injuries from blepharoplasty. Ophthal Plast Recons. 2024;40:374-379;DOI: 10.1097/IOP.0000000000002625
Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
© 2025 MJH Life Sciences

All rights reserved.